NCT03045497View on ClinicalTrials.gov

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 12, 2012

Primary Completion Date

December 5, 2013

Study Completion Date

December 5, 2013

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Perflutren Lipid Microspheres

Given IV

DEVICE

Dynamic Contrast-Enhanced Ultrasound Imaging

Undergo contrast-enhanced ultrasound imaging

DEVICE

Contrast-enhanced Magnetic Resonance Imaging

Undergo contrast-enhanced Magnetic Resonance Imaging

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03045497 - Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads | Biotech Hunter | Biotech Hunter